B of A Securities Initiates Coverage On Kura Oncology with Buy Rating, Announces Price Target of $31
Portfolio Pulse from richadhand@benzinga.com
B of A Securities analyst Jason Zemansky has initiated coverage on Kura Oncology (NASDAQ:KURA) with a Buy rating and a price target of $31.
August 11, 2023 | 2:21 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Kura Oncology has been initiated with a Buy rating by B of A Securities, with a price target of $31.
The initiation of coverage by B of A Securities with a Buy rating and a price target of $31 indicates a positive outlook for Kura Oncology. This could potentially attract more investors, driving the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100